Media Coverage

OmegaQuant has been featured in several articles and podcasts. Stay up-to-date on the latest health and nutrition information.

For media inquiries, please contact Becky Wright, Marketing & Communications Director:

Media Coverage

Nutritional Outlook’s 2019 Best of the Industry Awards, Retail Brand/Product: OmegaQuant

Published in Nutritional Outlook on December 3, 2019
The omega-3 category has had its highs and lows over the years. Occasional bad press has hurt public opinion about the benefits of omega-3 EPA and DHA supplements, affecting sales, but the category always seems to bounce back. That’s probably because omega-3s remain among the most well researched and recognized nutrients on the market. Read more.

#83 – Bill Harris, Ph.D.: Omega-3 fatty acids

Published in Peter Attia MD on December 9, 2019
In this episode, Bill Harris, Ph.D. in human nutrition and expert on omega-3 fatty acids, sets the table by clearly defining the families of fatty acids (saturated, monounsaturated, polyunsaturated) before diving into the current landscape of polyunsaturated fat (omega-6 and omega-3) with a particular focus on EPA and DHA (the two main elements of fish oil supplements). Bill gives a historical overview, updates us on the latest science related to the health benefits, and provides plenty of insights as to how we should think about increasing our EPA and DHA intake. Read more.

OmegaQuant Cheers Statement About Omega-3 Blood Testing

Published in WholeFoods Magazine on December 9, 2019
The International Society for the Study of Fatty Acids and Lipids (ISSFAL) has put together a formal statement regarding the importance of omega-3 blood testing in research studies, according to a press release from OmegaQuant. Read more.

ISSFAL publishes guidelines on analysis of omega-3 blood status in clinical research

Published in Nutraingredients USA on December 9, 2019
The International Society for the Study of Fatty Acids and Lipids (ISSFAL) has released new guidelines to encourage best practice in clinical trial design and study interpretation. Read more.

OmegaQuant partners with Australian agency to drive omega-3s research

Published in Nutraingredients USA on December 16, 2019
A new lab partnership will help drive omega-3s research in the Asia Pacific region, according to OmegaQuant, a firm that has developed a simple blood test to measure levels of these important nutrients. Read more.

Vascepa’s label expansion could boost supplement realm

Published in Nutraingredients USA on November 15, 2019
An expert panel has recommended an expanded treatment envelope for the EPA drug Vascepa. An expert says the move won’t affect the supplement market directly but does add to recent official recognition of the health benefits of omega-3s. Read more.

New Answers From Long-term Studies of Dietary Fats: Many Will Be Surprised

Published in WholeFoods Magazine on October 17, 2019   
A conversation with Dr. William S. Harris on the topic of new findings on fats. Read more. 

Why and How to Get DHA in Your Diet, with Dr. Kristina Harris Jackson

Published in on October 14, 2019
You may not have expected fish and pregnancy to go together. But it turns out that fish contain a critical fatty acid called DHA. DHA has been shown in numerous studies to lower women’s preterm birth risk, and supplementing with fish oil is an easy way to get enough DHA in your diet (algae is another option). How much is enough? And what about avoiding mercury? Dr. Kristina Harris Jackson, an expert in omega-3s and measuring DHA in blood, shares everything you need to know about safely optimizing your DHA level. Listen to the podcast.

Building Omega-3 Market Momentum

Published in Nutraceuticals World on October 1, 2019
The total value of the global omega-3 market in 2017 was $1.32 billion, up 2.3% from 2016, according to the Global Organization for EPA and DHA Omega-3 (GOED). Dietary supplements hold the largest share of value (54%), alongside infant formula (19.7%), pharmaceuticals (15.1%), pet foods (6.0%), and food and beverages (4.3%). Read more.

Omega Fatty Acids and Their Clinical Importance: An Opinion

Published in Tekno Science on September 25, 2019
One of the important conclusions drawn about fish oil (rich in EPA and DHA) by several contributors is that EPA and DHA are of benefit in the prevention of cardiovascular diseases and depression and anxiety. To achieve this beneficial action, it is suggested that an adult need to ake of 1g EPA + DHA per day. It was opined that increased intake of EPA/DHA could have prevented 227,000 European deaths during 2016. Read more.

Recent study devises “omega-3 calculator” to help researcher determine proper EPA and DHA doses

Published in Nutritional Outlook on August 28, 2019
A recent study published in the American Journal of Clinical Nutrition attempted to model the effects of omega-3 EPA and DHA supplementation on the omega-3 index of subjects. The model equation the researchers devised might make it possible to determine how much omega-3 EPA and DHA is needed to elevate the omega-3 index to the desired level. Read more.

Researchers develop “omega 3 calculator” to ensure the ideal dose

Published in Nutrition Insight on September 3, 2019
A study published in the American Journal of Clinical Nutrition will make it possible to calculate how much omega 3 EPA and DHA is needed in studies, for subjects to reach a healthy Omega 3 Index. The index measures the level of omega 3 EPA and DHA’s in the blood, and can be used as a risk factor for heart disease, among other conditions. The researchers highlight that dose likely played a role in the relative success or failure of previous studies that have focused on omega 3 as a research variable. Read more. 

New Study Allows Researchers to Calculate Proper Dose of Omega-3s

Published in WholeFoods Magazine on August 27, 2019
A new study published in The American Journal of Clinical Nutrition has made it possible for researchers to calculate how much omega-3 fatty acids they need to use in their studies in order for subjects to reach a healthy Omega-3 Index (O3I), according to a press release. Read more.

These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.